Jana ChisholmNov 15 min readEyes On October M&A activities, Approvals, and moreLast month, we had Eyes On some of the latest approvals, M&A and litigation. Read more about AbbVie, Genentech, Lundbeck, and GSK ...
Jana ChisholmJan 223 min readEyes on the New Year - 2024 has a Busy Start with Deals and Approvals2024 is off to a busy start with M&A activities highlighted at the JP Morgan Healthcare Conference, plus another Genetic Medicines approval.
Robin BatemanNov 26, 20222 min readEyes On Current EventsAfter all the quarterly results reporting, we've had eyes on product approvals, resubmissions, and a withdrawal.
Robin BatemanAug 18, 20226 min readHeartburn from ZantacThis week PharmaTell had Eyes On: Heartburn – the kind caused by the upcoming Zantac litigation & resulting market jitters.